Form 4 for CBT CABOT CORP
Accepted 2024-11-13 00:00:00 ET · period of report 2024-11-08 · accession 0000950170-24-126464 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-13 | 2024-11-11 | CBT | Kalkstein Hobart | EVP | M - OptEx | $64.62 | +20.6K | 62.8K | +49% | +$1.33M |
| DM | 2024-11-13 | 2024-11-11 | CBT | Kalkstein Hobart | EVP | S - Sale+OE | $115.23 | -34.8K | 50.6K | -41% | -$4.01M |
| D | 2024-11-13 | 2024-11-12 | CBT | Kalkstein Hobart | EVP | F - Tax | $112.54 | -2,303 | 48.3K | -5% | -$259.2K |
| D | 2024-11-13 | 2024-11-08 | CBT | Kalkstein Hobart | EVP | A - Grant | $0.00 | +3,130 | 64.8K | +5% | $0 |
| D | 2024-11-13 | 2024-11-08 | CBT | Kalkstein Hobart | EVP | A - Grant | $0.00 | +9,341 | 9,341 | New | $0 |
| DM | 2024-11-13 | 2024-11-11 | CBT | Kalkstein Hobart | EVP | M - OptEx | $0.00 | -20.6K | 5,594 | -79% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-11 | M | A | 8,390 | $73.84 | 59,017 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-11 | S | D | 8,390 | $115.02 | 50,627 | D | — | — | (F3) The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $115.000 to $115.325, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2024-11-12 | F | D | 2,303 | $112.54 | 48,324 | D | — | — | |
| 4 | Common | Common Stock | 2024-11-11 | S | D | 14,191 | $115.54 | 50,627 | D | — | — | (F1) The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $115.500 to $115.595, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2024-11-11 | M | A | 12,178 | $58.27 | 62,805 | D | — | — | |
| 6 | Common | Common Stock | 2024-11-11 | S | D | 12,178 | $115.00 | 50,627 | D | — | — | (F2) The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $115.000 to $115.040, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common Stock | 2024-11-08 | A | A | 3,130 | $0.00 | 64,818 | D | — | — | |
| 8 | Derivative | Employee Stock Option (Right to Buy) | 2024-11-08 | A | A | 9,341 | $0.00 | 9,341 | D | $114.99 · — to 2034-11-07 | 9,341 Common Stock | (F4) The option vests over a three year period as follows: 30% on November 8, 2025, 30% on November 8, 2026 and 40% on November 8, 2027. |
| 9 | Derivative | Employee Stock Option (Right to Buy) | 2024-11-11 | M | D | 12,178 | $0.00 | 8,119 | D | $58.27 · — to 2031-11-11 | 12,178 Common Stock | (F5) 20,297 shares were subject to the option. The option vested over a three year period as follows: 30% on November 12, 2022, 30% on November 12, 2023 and 40% on November 12, 2024. |
| 10 | Derivative | Employee Stock Option (Right to Buy) | 2024-11-11 | M | D | 8,390 | $0.00 | 5,594 | D | $73.84 · — to 2032-11-10 | 8,390 Common Stock | (F6) 13,984 shares were subject to the option. The option vested over a three year period as follows: 30% on November 11, 2023, 30% on November 11, 2024 and 40% on November 11, 2025. |